PATENT CLAIM ANALYSIS

Application Number: 16148028
Application Type: Utility
Filing Date: 2018-10
Publication Date: 2019-08
Patent Classification: ["514", "289000"]

Abstract:
This disclosure provides pharmaceutical compositions comprising dextromethorphan in combination with quinidine, and methods for treating agitation and/or aggression in subjects with dementia by administering such compositions.

Claim (Index 8):
The method according to  claim 6 , wherein the quinidine is in the form of quinidine sulfate.

Metadata:
- Claim Count in Document: 56.0
- Percentile: 97.0
- Lexical Diversity: 1.12
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['13415067', '11035213', '15211638', '14100597', '12080756']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.761726544761501
- 35 USC 102 Novelty (BERT): 0.5323003060244335
- Combined Prediction Score: 0.7387839208877943
- Mean Citation Score: 284.692826
- Max Citation Score: 352.63284
- Similarity Product: 226.0887369631433

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test